$72.36
1.161.63%
Last update: 1:54 PM
15 minutes delayed
Invesco Biotechnology & Genome ETF (ARCA: PBE) stock price, news, charts, stock research, profile.
Open | $72.12 |
High | $72.44 |
52 Wk High | $72.72 |
AUM | 264.20M |
Dividend | $0.06 |
Ex-Div Date | Jun 24, 2024 |
Volume | 2.79K |
Market Cap | $26.28B |
Mgmt Fee | 0.5% |
P/E Ratio | 28.60 |
Prev. Close | $71.20 |
Low | $72.10 |
52 Wk Low | $52.47 |
Shares Out | 4.04M |
Yield | 0.09% |
Div. Freq | Quarterly |
Avg. Volume Daily | 12.08K |
Beta | 0.81 |
Avg. Expense Ratio | NA% |
P/B Ratio | 3.79 |
Sector | Healthcare |
Category | High Performer-Mid Growth |
Investment Style | Mid Cap Growth |
Fund Inception | Jun 23, 2005 |
Managers | Tony Seisser Pratik Doshi Peter Hubbard Michael Jeanette |
Definition | This Equity Fund Portfolio contains majority of stocks with strong financial performance and average growth potential |
Symbol | Name | Share % |
---|---|---|
GILD | Gilead Sciences Inc | 5.48% |
ILMN | Illumina Inc - Common | 5.37% |
INCY | Incyte Corp. | 5.32% |
BMRN | Biomarin Pharmaceutica... | 5.09% |
VRTX | Vertex Pharmaceuticals... | 5.05% |
AMGN | Amgen Inc. | 4.98% |
REGN | Regeneron Pharmaceutic... | 4.97% |
NBIX | Neurocrine Biosciences... | 4.51% |
IONS | Ionis Pharmaceuticals ... | 3.24% |
HALO | Halozyme Therapeutics ... | 3.17% |